Protective Effects of N-Acetylcysteine in Concanavalin A-Induced Hepatitis in Mice

This study was designed to study the protective effects and mechanisms of N-acetylcysteine (NAC) in concanavalin A-induced hepatitis in mice. In this study, pretreatment with NAC ameliorated the histopathological changes and suppressed inflammatory cytokines in ConA-induced hepatitis. The expression of IL-2, IL-6, TNF-α, and IFN-γ was significantly reduced in the NAC-treated groups. NAC activated PI3K/Akt pathway and inhibited the activation of NF-κB. Additionally, NAC reduced autophagosome formation, as assessed by detecting the expression of LC3 and Beclin 1. Our results demonstrate that NAC can alleviate ConA-induced hepatitis by regulating the PI3K/Akt pathway and reducing the late stages of autophagy. Our results described a new pharmaceutical to provide more effective therapies for immune hepatitis.

[1]  Fan Wang,et al.  N-Acetylcysteine Attenuates Ischemia-Reperfusion-Induced Apoptosis and Autophagy in Mouse Liver via Regulation of the ROS/JNK/Bcl-2 Pathway , 2014, PloS one.

[2]  Fan Wang,et al.  15-Deoxy-γ12,14-prostaglandin J2 Reduces Liver Impairment in a Model of ConA-Induced Acute Hepatic Inflammation by Activation of PPARγ and Reduction in NF-κB Activity , 2014, PPAR research.

[3]  A. Czaja,et al.  Hepatic inflammation and progressive liver fibrosis in chronic liver disease. , 2014, World journal of gastroenterology.

[4]  T. K. Maiti,et al.  Role of PI3K/Akt/mTOR and MEK/ERK pathway in Concanavalin A induced autophagy in HeLa cells. , 2014, Chemico-biological interactions.

[5]  Haobo Li,et al.  N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes. , 2013, Free radical biology & medicine.

[6]  Fan Wang,et al.  Protective Effects of Necrostatin-1 against Concanavalin A-Induced Acute Hepatic Injury in Mice , 2013, Mediators of inflammation.

[7]  J. Schmid,et al.  The complexity of NF-κB signaling in inflammation and cancer , 2013, Molecular Cancer.

[8]  Michael Berk,et al.  The chemistry and biological activities of N-acetylcysteine. , 2013, Biochimica et biophysica acta.

[9]  P. Codogno,et al.  Autophagy in the liver. , 2013, Journal of hepatology.

[10]  J. Debnath,et al.  Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human disease. , 2013, Annual review of pathology.

[11]  Shun-cai Zhang,et al.  Curcumin Protects Against Concanavalin A-Induced Hepatitis in Mice Through Inhibiting the Cytoplasmic Translocation and Expression of High Mobility Group Box 1 , 2012, Inflammation.

[12]  G. Marenzi,et al.  N‐Acetylcysteine for the Prevention of Acute Kidney Injury After Cardiac Surgery , 2011, Journal of clinical pharmacology.

[13]  B. Han,et al.  Curcumin protects mice against concanavalin A-induced hepatitis by inhibiting intrahepatic intercellular adhesion molecule-1 (ICAM-1) and CXCL10 expression , 2011, Molecular and Cellular Biochemistry.

[14]  G. Nunnari,et al.  MicroRNA-122: a therapeutic target for hepatitis C virus (HCV) infection. , 2011, Frontiers in bioscience.

[15]  Olivier Poch,et al.  EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy , 2011, Nature Medicine.

[16]  B. Levine,et al.  Selective autophagy and viruses , 2011, Autophagy.

[17]  S. Jegatheeswaran,et al.  Experimental and clinical evidence for modification of hepatic ischaemia-reperfusion injury by N-acetylcysteine during major liver surgery. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[18]  R. Brunelli,et al.  Thiol Redox Transitions in Cell Signaling: a Lesson from N-Acetylcysteine , 2010, TheScientificWorldJournal.

[19]  Daniel J. Klionsky,et al.  Autophagy fights disease through cellular self-digestion , 2008, Nature.

[20]  D. Stolz,et al.  Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. , 2007, The American journal of pathology.

[21]  P. Thuluvath,et al.  Complementary and alternative medicine in hepatology: review of the evidence of efficacy. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[22]  M. Ahmad,et al.  Molecular mechanisms of N-acetylcysteine actions , 2003, Cellular and Molecular Life Sciences CMLS.

[23]  Inder M. Verma,et al.  NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.

[24]  Z. Tian,et al.  Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. , 2002, The Journal of clinical investigation.

[25]  I. Verma,et al.  NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.

[26]  L. Kaer,et al.  Critical contribution of liver natural killer T cells to a murine model of hepatitis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Kamata,et al.  N‐Acetylcysteine suppresses TNF‐induced NF‐κB activation through inhibition of IκB kinases , 2000, FEBS letters.

[28]  A. Dorner,et al.  Interleukin‐11 reduces T‐cell–dependent experimental liver injury in mice , 1999, Hepatology.

[29]  V. Heussler,et al.  The Inhibition of NF-B Activation Pathways and the Induction of Apoptosis by Dithiocarbamates in T Cells Are Blocked by the Glutathione Precursor N-Acetyl-L-Cysteine , 1999, Biological chemistry.

[30]  H. Fujiwara,et al.  Involvement of intrasinusoidal hemostasis in the development of concanavalin a–induced hepatic injury in mice , 1998, Hepatology.

[31]  S. Küsters,et al.  Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. , 1996, Gastroenterology.

[32]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[33]  A. Baldwin,et al.  The NF-kappa B and I kappa B proteins: new discoveries and insights. , 1996, Annual review of immunology.

[34]  M. Leist,et al.  Concanavalin A—induced T‐cell—mediated hepatic injury in mice: The role of tumor necrosis factor , 1995, Hepatology.

[35]  E. O’Neill,et al.  T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6 , 1994, The Journal of experimental medicine.

[36]  A. Wendel,et al.  A T cell-dependent experimental liver injury in mice inducible by concanavalin A. , 1992, The Journal of clinical investigation.